CSIMarket
 

Theravance Biopharma inc   (TBPH)
Other Ticker:  
 

Theravance Biopharma Inc 's Working Capital Per Sales

TBPH's Working Capital and Revenue growth



TBPH Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -63.11 % 37.14 % 46.57 % 69.77 % 59.93 %
Y / Y Revenue Change 26.04 % 24.43 % -21.06 % -1.99 % -5.63 %
Working Capital Per Revenue 3.96 5.35 5.41 4.76 4.08
Total Ranking # 2113 # 2140 # 3019 # 1609 # 1987
Seq. Working Capital Change -18.59 % -28.79 % -27.59 % -12.13 % 202.68 %
Seq. Revenue Change 14.14 % 31.99 % -28.89 % 17.65 % 12.68 %





Comment on TBPH's Working Capital Per Revenue in the third quarter 2023
Theravance Biopharma Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 3.96 below the company average.

Within Healthcare sector 40 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Theravance Biopharma Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 2113, from total ranking in the second quarter 2023 at 2140.
Working Capital Per Revenue Ranking
Within: No.
Industry # 13
Sector # 41
S&P 500 # 2113


Working Capital Per Revenue Statistics
High Average Low
185.51
13.25
3.36
(Dec 31 2017)   (Jun 30 2022)



Financial Statements
Theravance Biopharma Inc 's Working Capital $ 136 Millions Visit TBPH's Balance sheet
Theravance Biopharma Inc 's Revenues $ 16 Millions Visit TBPH's Income Statement
Where are TBPH's Sales coming from? Visit TBPH's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Longeveron Inc   10.80 
Ikena Oncology Inc   10.67 
Beam Therapeutics Inc   10.54 
Femasys Inc   9.42 
Atara Biotherapeutics Inc   9.39 
Kymera Therapeutics Inc   8.67 
Ngm Biopharmaceuticals Inc   8.65 
Tscan Therapeutics Inc   8.64 
Meiragtx Holdings Plc  8.37 
Xoma Corporation  8.21 
Tango Therapeutics Inc   8.02 
Recursion Pharmaceuticals Inc   7.93 
Predictive Oncology Inc   7.87 
Abeona Therapeutics Inc   7.74 
Foghorn Therapeutics Inc   7.74 
Caribou Biosciences Inc   7.26 
Dermtech Inc   7.07 
Hcw Biologics Inc   7.01 
Innovative Eyewear Inc   6.90 
Aclaris Therapeutics Inc   6.78 
Arcus Biosciences Inc   6.68 
Delcath Systems Inc   6.64 
Curis Inc   6.61 
Arcutis Biotherapeutics Inc   6.33 
Bluebird Bio Inc   6.30 
Nighthawk Biosciences inc   6.29 
Marinus Pharmaceuticals Inc   6.13 
Somalogic Inc   6.11 
Sutro Biopharma Inc   6.08 
Rewalk Robotics Ltd   6.03 
Date modified: 2023-11-12T05:51:15+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com